Jonathan M K Bogaerts

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Cognitive Impairment

Cardiovascular Disease

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Jonathan M K Bogaerts, Jacobijn Gussekloo, Bianca E M de Jong-Schmit, Saskia Le Cessie, Simon Pieter Mooijaart, Roos C van der Mast, Wilco P Achterberg, Rosalinde K E Poortvliet
Effects of the discontinuation of antihypertensive treatment on neuropsychiatric symptoms and quality of life in nursing home residents with dementia (DANTON): a multicentre, open-label, blinded-outcome, randomised controlled trial. Age and ageing 53 (7) (2024)
Jonathan M K Bogaerts, Jacobijn Gussekloo, Bianca E M de Jong-Schmit, Saskia Le Cessie, Simon Pieter Mooijaart, Roos C van der Mast, Wilco P Achterberg, Rosalinde K E Poortvliet
Effects of the discontinuation of antihypertensive treatment on neuropsychiatric symptoms and quality of life in nursing home residents with dementia (DANTON): a multicentre, open-label, blinded-outcome, randomised controlled trial. Age and ageing 53 (7) (2024)
Jonathan M K Bogaerts, Jacobijn Gussekloo, Bianca E M de Jong-Schmit, Saskia Le Cessie, Simon Pieter Mooijaart, Roos C van der Mast, Wilco P Achterberg, Rosalinde K E Poortvliet
Effects of the discontinuation of antihypertensive treatment on neuropsychiatric symptoms and quality of life in nursing home residents with dementia (DANTON): a multicentre, open-label, blinded-outcome, randomised controlled trial. Age and ageing 53 (7) (2024)
Jonathan M K Bogaerts, Leonie M von Ballmoos, Wilco P Achterberg, Jacobijn Gussekloo, Sven Streit, Milly A van der Ploeg, Yvonne M Drewes, Rosalinde K E Poortvliet
Do we AGREE on the targets of antihypertensive drug treatment in older adults: a systematic review of guidelines on primary prevention of cardiovascular diseases. Age and ageing (2021)